Jeffrey M. Taekman, MD and Melanie Clay Wright, PhD, from the Duke University Medical Center talk with GEN’s Editor-in-Chief John Sterling about human simulation technology to improve clinical trial design.

Previous articleCiphergen Sells Proteomics Business to Bio-Rad
Next articleBiomarker Found that Distinguishes between Alzheimer’s and other Forms of Dementia